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1. Introduction
The regeneration and functional recovery after a 
peripheral nerve injury (PNI) requires the occurrence 
of finely regulated events to remove the degenerated 
axons and myelin debris from the lesion site, so 
functional deficits can be compensated by regenerative 
mechanisms [1]. However, the recovery of gaps longer 
than 4 cm is minimal to non-existent [2], mainly due 
to extensive connective tissue scarring [3]. Autografts 
are the ‘gold standard’ procedure in clinics for the 
surgical repair of damaged nerves. However, this 
technique presents several limitations, being reported 
that only 40–50% of patients regain proper motor 
and sensorial function [4]. Therefore, there is a clear 
need to find strategies that overcome the autograft’s 
drawbacks. In an attempt to ameliorate the process 
of nerve regeneration, tissue-engineering-based 
approaches are being explored. They are based on the 
premise that the bridges used for the reconnection of 
the two nerve stumps should have a more amenable 
microenvironment to promote the survival of the 
axotomized host neuronal populations, while guiding 
axons through the nerve gap [5]. One possible route 
to follow is the use of hydrogel-based biomaterials 
enriched with extracellular matrix (ECM) molecules, 
supportive cells, and exogenous factors to stimulate 
the different steps of regeneration. In fact, the 
R C Assunção-Silva et al
Printed in the UK
051001
BMBUCS
© 2015 IOP Publishing Ltd
2015
10
Biomed. Mater.
BMM
1748-6041
10.1088/1748-6041/10/5/051001
5
1
7
Biomedical Materials
JW
20
October
2015
Induction of neurite outgrowth in 3D hydrogel-based environments
Rita C Assunção-Silva1,2,4, Cátia Costa Oliveira1,2,4, Ofra Ziv-Polat3, Eduardo D Gomes1,2, Abraham Sahar3, 
Nuno Sousa1,2, Nuno A Silva1,2 and António J Salgado1,2
1 Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4701-057 
Braga, Portugal
2 ICVS/3B’s—PT Government Associate Laboratory, Braga/Guimarães, Portugal
3 NVR Research Ltd, Ness-Ziona, 74031, Israel
4  R C Assunção-Silva and C C Oliveira contributed equally to this work.
E-mail: asalgado@ecsaude.uminho.pt
Keywords:  gellan-gum hydrogels, GRGDS, adipose tissue-derived stem cells, glial-cell line derived neurotrophic factor, iron oxide 
nanoparticles, peripheral nerve repair
Abstract
The ability of peripheral nervous system (PNS) axons to regenerate and re-innervate their targets 
after an injury has been widely recognized. However, despite the considerable advances made in 
microsurgical techniques, complete functional recovery is rarely achieved, especially for severe 
peripheral nerve injuries (PNIs). Therefore, alternative therapies that can successfully repair 
peripheral nerves are still essential. In recent years the use of biodegradable hydrogels enriched with 
growth-supporting and guidance cues, cell transplantation, and biomolecular therapies have been 
explored for the treatment of PNIs. Bearing this in mind, the aim of this study was to assess whether 
Gly-Arg-Gly-Asp-Ser synthetic peptide (GRGDS)-modified gellan gum (GG) based hydrogels could 
foster an amenable environment for neurite/axonal growth. Additionally, strategies to further improve 
the rate of neurite outgrowth were also tested, namely the use of adipose tissue derived stem cells 
(ASCs), as well as the glial derived neurotrophic factor (GDNF). In order to increase its stability and 
enhance its bioactivity, the GDNF was conjugated covalently to iron oxide nanoparticles (IONPs). The 
impact of hydrogel modification as well as the effect of the GDNF-IONPs on ASC behavior was also 
screened. The results revealed that the GRGDS-GG hydrogel was able to support dorsal root ganglia 
(DRG)-based neurite outgrowth, which was not observed for non-modified hydrogels. Moreover, the 
modified hydrogels were also able to support ASCs attachment. In contrast, the presence of the GDNF-
IONPs had no positive or negative impact on ASC behavior. Further experiments revealed that the 
presence of ASCs in the hydrogel improved axonal growth. On the other hand, GDNF-IONPs alone 
or combined with ASCs significantly increased neurite outgrowth from DRGs, suggesting a beneficial 
role of the proposed strategy for future applications in PNI regenerative medicine.
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incorporation of ECM molecules into such biomaterials 
has been shown to provide adhesion sites and 
stimulate neurite extension in vitro and in vivo [6, 7]. 
Among the available hydrogels, gellan-gum (GG) is an 
interesting candidate for regenerative purposes because 
of its biocompatibility, biodegradability, and similarity 
to host tissues [8–11]. Indeed, we have previously 
shown that this biomaterial has suitable properties 
for nervous system repair [12]. Moreover, our lab 
has shown that GG modification with Gly-Arg-Gly-
Asp-Ser (GRGDS) peptidic sequences improves cell 
adhesion, proliferation, migration, and the metabolic 
activity of different cell types [13, 14], including neural 
stem cells, olfactory ensheathing cells, and those with a 
mesenchymal stem cell-like phenotype, in comparison 
to non-modified GG.
In addition to the use of ECM-containing hydrogels 
for PNI treatment, the presence of exogenous  factors 
in the peripheral nerve microenvironment appears to 
be crucial for nerve regeneration [15]. Their introduc-
tion in the injury site may be achieved through the 
transplantation of cells capable of secreting several 
growth factors and biomolecules that may improve 
the overall regeneration. Adipose tissue-derived 
mesenchymal stem cells (ASCs) [16] are particularly 
appealing for this purpose. Indeed, their secretome 
is known to contain high concentrations of neuro-
trophic factors, immunomodulatory and hematopoi-
etic cytokines, as well as angiogenic and anti-apoptotic 
proteins [17] with neuroprotective activity [18, 19]. 
On the other hand, several growth factors have been 
identified as important for nerve repair by supporting 
axonal growth and improving resident schwann cell 
(SC) migration and proliferation within the  damaged 
nerve [20]. Among these, the glial derived neuro-
trophic factor (GDNF) has been described as a potent 
promoter of neuronal survival and axonal sprouting 
in PNIs [20–22]. However, the use of soluble factors in 
these strategies is a challenge. Their short-term effect 
in vivo requires a continuous application in order to 
obtain a therapeutic effect [23]. In order to increase 
its stability and extend its bioavailability and biologi-
cal activity, GDNF was conjugated covalently to iron 
oxide nanoparticles (IONPs) [24, 25]. Furthermore, 
IONPs have magnetic properties which can be used 
for reloading the scaffold in vivo with growth factor 
conjugated IONPs using an external magnetic field, as 
well as for tracking IONPs in vivo by MRI. Taking this 
into consideration, a strategy that could combine the 
beneficial immunomodulatory and regenerative 
properties of MSCs with the increased stability and 
delivery of growth factors provided by IONPs could 
represent an added value to foster the growth of injured 
nerves.
So far, no studies have been reported on the influ-
ence of GRGDS-GG hydrogels on neurite outgrowth. 
Therefore, we herein aim to first determine the ability of 
the modified GG-hydrogels in promoting axonal out-
growth in an in vitro model based on dorsal root  ganglia 
(DRG) explants [26]. Upon this initial assessment the 
objective was to determine if the observed axonal out-
growth could be potentiated by co-culturing DRGs on 
GG-GRGDS hydrogels in the presence of ASCs and 
GDNF conjugated to IONPs.
2. Materials and methods
2.1. Synthesis of GDNF conjugated iron-oxide 
nanoparticles
Dextran-coated IONPs were prepared according 
to Molday and MacKenzie [26]. The GDNF 
(PeproTechAsia, Israel) was then conjugated covalently 
to the surface of the IONPs as described previously 
[25]. Briefly, the nanoparticles’ dextran coating layer 
was functionalized with activated double bonds by 
the interaction between the hydroxyl groups of the 
dextran and divinyl sulfone (DVS) via the Michael 
addition reaction. The formed DVS-derivatized 
IONPs were then used for the covalent binding of the 
neurotrophic factor, again via the Michael addition 
reaction. The concentration of GDNF conjugated to the 
nanoparticles was determined by an appropriate ELISA 
Kit (PeproTech Asia, Israel).
2.2. Functionalization of GG hydrogel with GRGDS 
peptide
The GG hydrogel was modified with the GRGDS 
peptide as previously described [13]. First, GG (Sigma, 
USA) was modified with furan molecules (furan-
GG). Briefly, GG was dissolved in 2-(N-morpholino) 
ethanesulfonic acid (MES) buffer (100 mM, pH 5.5) 
at 37 °C. 4-(4,6-Dimethoxy-1,3,3-triazin-2-yl)-4-
methylmorpholinium chloride (DMT-MM, Sigma, 
USA) and furfurylamine (Acros Organics, Belgium) 
were then added in a 4 : 1 molar ratio (of each reagent 
relative to the COOH- groups in GG) and stirred at 
37 °C for 48 h. The obtained solution was dialyzed 
alternately against distilled water and PBS (0.1 M, pH 
7.2) for 5 d. Furan-GG was then lyophilized to remove 
the water. The immobilization of the maleimide-
containing GRGDS peptide (Mal-GRGDS, AnsSpec, 
USA) to furan-modified GG was performed via Diels-
Alder chemistry between the GRGDS maleimide 
functional group and the GG furan group. To 
accomplish this, furan-GG was dissolved in MES buffer 
at 37 °C, to which Mal-GRGDS was then added in a 
5 : 1 maleimide-furan molar ratio. After vigorous 
stirring for 48 h at 37 °C, the solution was dialyzed 
exactly as described above. After 5 d, water was removed 
from GRGDS-GG by lyophilization. As previously 
reported, a GG modification of approximately 300 
nmol of GRGDS peptide covalently bound per 
milligram of GG is achieved using this protocol [13].
2.3. DRG isolation and culture on top  
of GRGDS-GG hydrogels
DRGs from 5 d-old neonatal Wistar-Han rat pups 
were dissected under sterile conditions. The DRGs 
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were then placed on top of 50 μl drops of GRGDS-GG 
hydrogels and kept in culture in 24 well plates for 4 d in 
neurobasal medium (Gibco) supplemented with B27, 
L-glutamine, glucose, and 1% penicillin-streptomycin. 
DRG culture on top of non-modified GG was used as 
a control. Immunocytochemistry for neurofilament 
staining was performed to analyze the DRG axonal 
growth in the gels.
2.4. ASC Culture and GDNF iron-oxide 
nanoparticles cytotoxicity
The cryopreserved ASCs were a kind gift from 
Professor Jeff Gimble (Tulane University Center for 
Stem Cell Research and Regenerative Medicine and 
LaCell LLC (New Orleans, Louisiana, USA)). The 
cells were isolated according to Dubois et al [27] and 
cultured in complete α-MEM [Invitrogen, USA; 
supplemented with 10% Fetal Bovine Serum (FBS) and 
1% Penicillin-Streptomycin (P/S)] at 37 °C with 5% of 
CO2. The culture medium was renewed every 2 d. Upon 
confluence, the cells were trypsinized and passed to new 
T75 flasks.
For cell counting assays, P9 ASCs were seeded 
in wells of 24 well plates at a cell density of 5  ×  104 
cell ml−1 and allowed to attach for 48 h in complete 
α-MEM at 37 °C in 5% CO2. Then, the GDNF- 
conjugated NPs (10 ng ml−1) were added to the cell 
culture medium (n  =  6). The ASC culture in com-
plete α-MEM without GDNF-IONPs was used as a 
control (n  =  6). The cells were kept for an additional 
7 d, after which the cell densities were assessed. Phal-
loidin (Sigma-Aldrich, USA)/DAPI (Invitrogen, USA) 
staining was performed and samples were analyzed by 
confocal microscopy (Olympus FV1200). Six repre-
sentative fields per sample (n  =  6) were chosen and 
analyzed at a 20  ×  magnification. The DAPI+ cells 
were manually selected using Image J (NIH) software. 
Thereafter, the total number of cells per observed field 
was automatically calculated by the software and data 
analyzed.
2.5. Cell encapsulation within the GRGDS-GG 
hydrogels
In order to encapsulate ASCs in the modified gels, both 
GG and GRGDS-GG were dissolved in ultra-pure 
water to obtain a gel concentration of 1% (w/v), at 
90 °C for 30 min and at 40 °C overnight, respectively. 
Both solutions were then mixed in a 50 : 50 GG:GRGDS-
GG ratio. Calcium chloride (CaCl2) was then added to 
the gel solution diluted 1 : 10 allowing the gelification 
process to occur. Finally, P9 ASCs were encapsulated 
in the modified-GG hydrogel at a cell density of 
6  ×  106cells ml−1. Triplicates with 50 μl of gel each 
were kept in culture in a neuron medium (Invitrogen; 
[Neurobasal medium (Gibco) supplemented with 
B27, L-glutamine, glucose, and 1% Penicillin-
Streptomycin]) for 4 d.
To observe the ASC morphology in GRGDS-GG 
hydrogels in a neuron medium, triplicates of 50 μl 
of each gel were kept in culture for 4 d in the referred 
medium supplemented with GDNF-IONPs (10 ng 
ml−1) using Lab-Tek chambered coverglass. The ASC 
culture within the GRGDS-GG with a regular neuron 
medium was used as a control. At the end of the culture, 
Phalloidin/DAPI staining was performed and confocal 
microscopy images were taken.
2.6. DRG co-culture with ASCs and GDNF-IONPs 
in GRGDS-GG hydrogels
As previously described, the ASCs were encapsulated 
within the GRGDS-GG hydrogels at a concentration 
of 6  ×  106 cells ml−1. Four replicates of 50 μl of each 
were maintained in complete α-MEM for 24 h. After 
this time, the DRGs from 5 d-old neonatal Wistar-Han 
rat pups were dissected as previously described, placed 
on top of the ASC-containing hydrogels, and kept in 
culture for 4 d in neuron medium supplemented with 
GDNF-IONPs (10 ng ml−1). The purpose of using 
this particular time point was to assess the effects of 
the tested strategy on the initial growth of new axons, 
and whether this could be accelerated by it. The DRG 
culture on top of GRGDS-GG alone, in the absence 
(DRGctr) or presence of GDNF-IONPs (DRG+NPs) 
was used as a control. Moreover, the DRG culture 
on top of the ASC-containing gels without GDNF-
IONP supplementat ion (DRG+ASCs)  was 
also used as a control, as summarized in table 1. 
Immunocytochemistry was performed to evaluate 
the DRG neurite outgrowth within the gels.
2.7. Immunocytochemistry and Phalloidin/DAPI 
staining
For the immunocytochemistry staining, the 
following antibodies were used: Mouse monoclonal 
anti-human neurofilament 200 kDa (Millipore) as 
the primary antibody and Alexa fluor 488 goat anti-
mouse IgG (Invitrogen) as the secondary antibody. 
After 4 d of culture, the samples were fixed in a PBS 
Table 1. Combination of the materials and cells used in the present experiment.
Conditions used Cell culture system
DRG ctr DRG culture in GRGDS-GG alone.
DRG  +  ASCs Co-culture of DRGs with ASC containing GRGDS-GG hydrogels.
DRG  +  NPs DRG culture in GRGDS-GG alone; GDNF-IONPs addition to the cell culture medium.
DRG  +  ASC  +  NPs Co-culture of DRGs with ASC containing GRGDS-GG hydrogels; GFDF-IONPs addition 
to the cell culture medium.
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solution containing 4% paraformaldehyde (PFA) for 
45 min at room temperature (RT) and then washed 
with PBS. For cell membrane permeabilization, the 
samples were incubated with 0.3% Triton X-100 
(Sigma, USA) for 10 min at RT, and then washed 
three times with PBS. A blocking buffer solution 
[PBS containing 10% fetal bovine serum (FBS)] was 
used for blocking for 90 min at RT, after which the 
samples were incubated with the primary antibody 
(diluted 1 : 200 in PBS solution with 10% FBS) for 
48 h at 4 °C. Subsequently, the samples were again 
washed three times with PBS solution containing 
0.5% FBS, and incubated with the secondary 
antibody (diluted 1 : 1000 in PBS/0.5%FBS solution) 
overnight at 4 °C.
For Phalloidin/DAPI staining, the cells were fixed 
with 4% PFA for either for 30 or 45 min (in wells or 
in GRGDS-GG, respectively) at RT, washed with PBS 
and permeabilized with 0.3% Triton X-100. After PBS 
washing, Phalloidin (0.1 μg ml−1; Sigma) and DAPI (1 
μg ml−1; Invitrogen) were added to the cells for 30 or 
45 min (in wells or GRGDS-GG, respectively).
2.8. DRG neurite outgrowth quantification
The confocal images of the DRG explants cultured on 
the GG-GRGDS hydrogels were analyzed with Image 
J software in order to quantify the area occupied by the 
neurites within the gel [28]. For this, the image scale 
was first set and the area occupied by the DRG itself was 
excluded. The images were then converted to 8 bits and 
binary. Through the ‘analyze particles’ menu, the software 
automatically calculated the area of neurite outgrowth, 
considering the image’s dark background as a contrast.
2.9. Statistical analysis
The statistical analyses were performed using Graph-
Pad Prism Software (version 5.00 for Windows). A 
t-student test was used for the cell counting assays, 
whereas a one-way ANOVA, following by a Tukey 
post-hoc multiple comparisons test, were used for 
the quantification of the area of neurite outgrowth. 
Statistical significance was defined as p  ⩽  0.05 for 
a 95%  confidence level. The data were presented as 
mean  ±  standard deviation (Mean  ±  SD).
3. Results
3.1. DRG cultures on GRGDS-GG hydrogels
DRG explants were cultured on top of GRGDS-GG 
hydrogels in a neuron medium for 4 d. Immunocy-
tochemistry for neurofilament staining was then per-
formed, followed by confocal microscopy analysis in 
order to observe the axonal growth from the DRGs.
As shown in figure 1, the insertion of GRGDS pep-
tides into GG was beneficial for neurite outgrowth. In 
fact, while in the modified GG-GRGDS hydrogel it is 
possible to observe a high degree of neurite arboriza-
tion and growth, in the native form of the hydrogel 
none of these phenomena were witnessed.
3.2. Combination of GRGDS-GG hydrogels with 
ASCs and GDNF-IONPs
3.2.1. Biological effect of GRGDS-GG and GDNF-
IONPs on ASCs 
In order to determine the impact of the GDNF-
conjugated iron nanoparticles on ASC morphology and 
cell densities, the latter were cultured in the presence of 
the NPs in both 2D (figures 2(a) and (b)) and 3D culture 
(figures 2(c) and (d)) systems. The ASCs were found to 
extend their cytoplasmic processes in both 2D and 3D 
environments, acquiring their typical fibroblast-like 
morphology [29]. Moreover, the cell densities of the 
ASCs (figure 2(e)) were not significantly affected by the 
supplementation and presence of GDNF-conjugated 
NPs. (ASC  +  NPs; 17,4  ±  3,60 DAPI+ cells), when 
compared to the ASC culture in a regular medium (ASC 
ctr; 16,5  ±  1,05 DAPI+ cells).
3.2.2. Co-culture of DRG explants with ASCs and 
GDNF-IONPs in GRGDS-GG hydrogel 
The immunocytochemistry analyses on the growth 
of DRG neurites in the modified GG showed that the 
hydrogel by itself was able to support axonal growth 
(figure 3(a); DRG ctr). This effect was further potentiated 
Figure 1. Axonal growth from DRG explants cultured on gellan-gum hydrogels. After 4 d of cell culture, immunocytochemistry 
analysis revealed that the GRGDS-GG gels promoted DRG’s axonal growth, when compared to regular gels (non-modified GG).
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by co-culturing DRGs with ASCs and GDNF-IONPs 
(figure 3(a); DRG  +  ASCs; DRG  +  GDNF-IONPs; 
DRG  +  ASCs  +  GFDF-IONPs).
This qualitative analysis was further corroborated 
by quantifying the area of neurite outgrowth of the DRG 
explants in the GRGDS-GG hydrogels (figure 3(b)). The 
co-culture of DRGs with ASCs (DRG  +  ASCs) had an 
11-fold increase in the area of neurite outgrowth (μm2), 
in comparison with DRGs cultured in GRGDS-GG 
alone (DRG ctr). This indicates a positive effect of ASCs 
on the axonal growth, although no statistical differences 
were observed. The presence of the GDNF-IONPs 
in culture promoted a significantly higher neurite 
outgrowth in comparison with the control (DRG 
ctr) in a 24-fold (DRG  +  NPs) and 26-fold increase 
(DRG  +  ASC  +  NPs), respectively. However, there was 
no significant difference in the DRG neurite outgrowth 
between cultures treated with ASCs combined with 
GDNF-IONPs (DRG  +  ASCs  +  NPs) and cultures 
treated with GDNF-IONPs alone (DRG  +  NPs).
4. Discussion
The use of gellan-gum hydrogels in combination 
with GRGDS peptidic sequences was herein studied, 
Figure 2. Morphology and density of ASCs on 2D and 3D cell culture systems. Confocal analyses revealed similar morphology 
of ASCs when encapsulated within the GRGDS-GG hydrogels and cultured on the 2D environment, both in the absence (a,c) or 
presence (b,d) of GDNF-IONPs. The cell cytoplasm was stained with phalloidin (red) and the nuclei counterstained with DAPI 
(blue). The cell density (e) was also found to be similar either in the absence or presence of the GDNF-IONPs. (n  =  6; Mean  ±  SD).
Figure 3. DRG neurite outgrowth in ASCs-containing GRGDS-GG and GDNF-NPs. (a) Immunocytochemistry analyses of the 
DRG culture on top of GRGDS-GG hydrogels after 4 d revealed an extensive axonal growth throughout the gel, more pronounced 
in the presence of GDNF-IONPs, in comparison to the DRG cultured either in GG alone (DRG ctr) and ASC-containing hydrogels 
(DRG  +  ASC). (b) Quantification of the DRG neurite outgrowth area (μm2) was confirmed to be significantly higher in the 
presence of GFDF-IONPs (DRG  +  NPs; DRG  +  ASCs  +  NPs) versus DRG ctr. (n  =  4; mean  ±  SD; * P  <  0.05).
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followed by their combination with ASCs and 
exogenous GDNF-conjugated to IONPs.
As hydrogels have been unsatisfactory in support-
ing nerve regeneration [30], their functionalization 
with ECM molecules such as GRGDS peptides could 
be advantageous for promoting axonal growth in 
vitro. In the present study, we demonstrated that the 
GRGDS-GG hydrogel by itself was able to support 
DRG  neurite outgrowth. The addition of this peptide to 
other polymers such as collagen and polyethylene glycol 
also showed to improve neurite extension and density 
[7, 31]. Curiously, Ferris and colleagues [10] showed 
that the addition of RGD to purified GG did not sig-
nificantly impact the behavior of PC12 cells. This fact 
could be related to the conformation of the peptide 
itself within the modified GG, or with the in vitro cell 
system used for this work. Although PC12 cells are a 
neuronal cell line, they do not disclose all the properties 
of the primary or explant cultures of CNS/PNS derived 
tissues, a fact that could impact the outcomes of such 
experiments. Other modified ECM-like hydrogels, 
such as elastin-based gels, were shown to significantly 
improve neurite outgrowth and the extension of DRG 
explants when compared to non-modified hydrogels 
[32]. These studies suggest that other ECM molecules 
may be used for GG modification, namely laminin or 
elastin, to improve GG performance in promoting 
axonal regeneration.
One of the possible existing routes to increase neurite/
axonal growth within 3D hydrogels is through the use 
of mesenchymal-like stem cells, such as those derived 
from the adipose tissue (ASCs). In fact, these cells are 
known to have a secretome rich in immunomodulatory 
and hematopoietic cytokines [33], as well as angiogenic 
and anti-apoptotic proteins [34], and neuroregulatory 
molecules, some of which with a direct impact on nerve 
growth [17, 35]. Therefore, we set out to determine if 
ASCs could be cultured within the GG-GRGDS ECM-
like matrix on one hand, and on the other if they could 
promote neurite/axonal growth. The results revealed 
that, in fact, GG-GRGDS-based hydrogels were able 
to promote ASC attachment and growth, reflecting 
the cell-GRGDS peptides interaction. In fact, this is in 
line with what has been previously reported by our and 
other laboratories [10, 13, 14]. For instance, Ferris and 
 colleagues revealed that by modifying a purified version 
of GG with an RGD containing peptide it was possible to 
support the growth of C2C12 cells [10]. Regarding the 
effects of ASCs on axonal growth, an improvement of 
DRG neurite outgrowth was observed when ASCs were 
present in the hydrogel, although with no statistical 
difference. Furthermore, the use of exogenous GDNF-
conjugated IONPs in the in vitro system had clearly 
improved DRG axonal growth in the GRGDS-GG gels. 
This effect of GDNF on axonal growth was already 
expected since this factor was previously described as a 
potent neuroprotector and neurite branching promoter 
and extremely important for neuronal survival and 
nerve regeneration following a PNI [36].
Finally, when ASCs and GFDF-IONPs were used in 
combination in the GRGDS-GG hydrogels, no cyto-
toxic effect of the NPs on ASC was observed, suggest-
ing these two approaches are suitable for a combined 
therapy. Indeed, the neurite outgrowth from DRGs was 
significantly improved when ASCs and GDNF-IONPs 
were used in a cell culture system when compared to the 
control. However, it appears that there is no synergistic 
effect of the two approaches, as no significant differ-
ences were observed between the use of ASCs com-
bined with GDNF-IONPs and GDNF-IONPs alone. 
This fact may be due to a higher concentration of the 
exogenous GDNF than the factors secreted by ASCs, 
therefore attributing the observed effect solely to the 
presence of the GDNF in the cell culture system. Nev-
ertheless, ASCs secretome is widely described to also 
have a non-inflammatory [17], non-apoptotic, and 
angiogenic [34] character, being able to foster an envi-
ronment amenable to inducing regeneration. Bearing 
this in mind it is possible to envisage a combined ther-
apy in which ASCs, through their secretome, protect 
the injured tissue, and with it create an environment 
favorable for regeneration, while axonal growth will be 
stimulated by the GDNF bound to IONPs.
5. Conclusions
GRGDS-GG hydrogels alone were able to promote 
DRG neurite outgrowth. The modified gels also 
showed their for support ASC attachment and growth, 
as well as potentiated DRG axonal growth, when 
compared to the controls. These results revealed the 
importance of introducing chemical cues within 
hydrogels in order to obtain axonal growth for 
future application in PNI treatment. Similarly, the 
administration of GDNF-IONPs to the cell culture 
system also promoted a significantly higher DRG 
neurite outgrowth in comparison to the control. 
Finally, the combination of ASCs containing GRGDS-
GG hydrogels and GDNF-IONPs was shown to 
significantly improve DRG axonal growth versus the 
control, without any detrimental effect of the NPs on 
cell behavior, although no cumulative effect of ASCs 
and GDNF-IONPs was observed.
According to the results obtained here, the combi-
nation of these three strategies can represent an option 
for PNI-related therapies. Future work will focus on the 
impact of GDNF-IONPs, as well as of the GRGDS pep-
tide, on ASC secretome in order to study more closely its 
regenerative potential for PNI applications.
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